Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Coherus BioSciences Inc (NASDAQ:CHRS)

8.60
Delayed Data
As of Dec 11
 0.00 / 0.00%
Today’s Change
8.05
Today|||52-Week Range
29.59
-69.45%
Year-to-Date
No recent news for Coherus BioSciences Inc.

Today’s Trading

Previous close8.60
Today’s open9.40
Day’s range8.55 - 9.43
Volume417,613
Average volume (3 months)548,999
Market cap$498.3M
Data as of 4:00pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)+49.42%
Earnings growth (this year)-51.04%
Earnings growth (next 5 years)--
Revenue growth (last year)+532.82%
P/E ratioNM
Price/Sales6.21
Price/Book19.19

Competitors

 Today’s
change
Today’s
% change
NTLAIntellia Therapeutic...0.000.00%
IMGNImmunoGen Inc0.000.00%
CRSPCRISPR Therapeutics ...0.000.00%
MYOVMyovant Sciences Ltd0.000.00%
Data as of 4:02pm ET, 12/11/2017

Financials

Next reporting dateMarch 26, 2018
EPS forecast (this quarter)-$0.88
Annual revenue (last year)$190.1M
Annual profit (last year)-$127.3M
Net profit margin-66.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Denny M. Lanfear
Chief Financial Officer
Jean-Frédéric Viret
Corporate headquarters
Redwood City, California

Forecasts